Experienced in Thymectomy

Dr. Charles B. Simone

Hematology Oncology | Public Health and Preventive Medicine
123 Franklin Corner Rd, Suite 108, 
Lawrenceville, NJ 
Experienced in Thymectomy
123 Franklin Corner Rd, Suite 108, 
Lawrenceville, NJ 
OverviewInsuranceLocationsClinical ResearchSimilar Doctors

Overview

Charles Simone is a Hematologist Oncology specialist and a Public Health and Preventive Medicine provider in Lawrenceville, New Jersey. Dr. Simone is rated as an Experienced provider by MediFind in Thymectomy. His top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Mesothelioma, Prostatectomy, and Thymectomy.

His clinical research consists of co-authoring 626 peer reviewed articles and participating in 11 clinical trials. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 2 articles in the study of Thymectomy.

Specialties
Hematology Oncology
Public Health and Preventive Medicine
Licenses
Internal Medicine in NJ
Languages Spoken
English
Gender
Male

Insurance

Accepted insurance can change. Please verify directly with the provider.

Find your insurance
Find your insuranceClose

Accepted insurance plans:

Aetna
  • EPO
  • HMO
  • POS
  • PPO
Anthem
  • EPO
  • HMO
  • POS
  • PPO
Blue Cross Blue Shield
  • EPO
  • HMO
  • POS
  • PPO
Cigna
  • EPO
  • HMO
  • PPO
Horizon Healthcare
  • EPO
  • POS
Independent Health
  • EPO
  • POS
  • PPO
UnitedHealthcare
  • EPO
  • HMO
  • POS
  • PPO
View 2 Less Insurance Carriers -

Locations

123 Franklin Corner Rd, Suite 108, Lawrenceville, NJ 08648

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Providers who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

11 Clinical Trials

A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
A Randomized Phase III Trial of Induction/Consolidation Atezolizumab (NSC #783608) + SBRT Versus SBRT Alone in High Risk, Early Stage NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: September 03, 2025
Intervention Type: Other, Drug, Procedure, Radiation
Study Drug: Atezolizumab
Study Phase: Phase 3
LCI-LUN-NSC-SBRT-001: Phase II Prospective Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation and Adjuvant Immunotherapy for Locally-Advanced Non-Small Cell Lung Cancer
LCI-LUN-NSC-SBRT-001: Phase II Prospective Trial of Primary Lung Tumor Stereotactic Body Radiation Therapy Followed by Concurrent Mediastinal Chemoradiation and Adjuvant Immunotherapy for Locally-Advanced Non-Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: July 18, 2025
Intervention Type: Drug, Radiation
Study Drugs: Carboplatin, Paclitaxel, cis Platinum, Etoposide, Durvalumab
Study Phase: Phase 2
Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases
Prospective Follow-up of Outcomes in Patients Receiving Photodynamic Therapy for Neoplastic Diseases
Enrollment Status: Active_not_recruiting
Publish Date: July 02, 2025
Intervention Type: Other
Human Blood Collection to Serve as Negative Control for Validation of Circulating Tumor Cell Assay
Human Blood Collection to Serve as Negative Control for Validation of Circulating Tumor Cell Assay
Enrollment Status: Active_not_recruiting
Publish Date: January 28, 2025
Intervention Type: Other
Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC
Phase III Randomized Trial Comparing Overall Survival After Photon Versus Proton Chemoradiotherapy for Inoperable Stage II-IIIB NSCLC
Enrollment Status: Active_not_recruiting
Publish Date: December 18, 2024
Intervention Type: Other, Drug, Biological, Radiation
Study Drugs: Carboplatin, Cisplatin, Durvalumab, Etoposide, Paclitaxel, Pemetrexed Disodium
Study Phase: Phase 3
The Detection Of Circulating Tumor Cells (CTC) In Patients With Non-small Cell Lung Cancer (NSCLC) Undergoing Definitive Radiotherapy Or Chemoradiotherapy
The Detection Of Circulating Tumor Cells (CTC) In Patients With Non-small Cell Lung Cancer (NSCLC) Undergoing Definitive Radiotherapy Or Chemoradiotherapy
Enrollment Status: Completed
Publish Date: November 20, 2024
Intervention Type: Radiation
A Phase I/II Clinical Study Evaluating the Safety and Effectiveness of BIO 300 Oral Suspension in Patients Receiving Chemoradiation Therapy for Non-Small Cell Lung Cancer (NSCLC)
A Phase I/II Clinical Study Evaluating the Safety and Effectiveness of BIO 300 Oral Suspension in Patients Receiving Chemoradiation Therapy for Non-Small Cell Lung Cancer (NSCLC)
Enrollment Status: Completed
Publish Date: January 25, 2024
Intervention Type: Drug, Radiation
Study Phase: Phase 1/Phase 2
Moving PD-1 Blockade With Pembrolizumab Into Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer
Moving PD-1 Blockade With Pembrolizumab Into Concurrent Chemoradiation for Locally Advanced Non-Small Cell Lung Cancer
Enrollment Status: Active_not_recruiting
Publish Date: December 14, 2023
Intervention Type: Radiation, Drug, Other, Biological
Study Drugs: Carboplatin, Paclitaxel, Pembrolizumab
Study Phase: Phase 1
Cardiac Magnetic Resonance Imaging and Biomarker Testing for Evaluating Cardiac Injury Resulting From Radiation Therapy in Cancer: A Pilot Study
Cardiac Magnetic Resonance Imaging and Biomarker Testing for Evaluating Cardiac Injury Resulting From Radiation Therapy in Cancer: A Pilot Study
Enrollment Status: Terminated
Publish Date: October 13, 2022
Intervention Type: Other
A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy
A Volume, Motion, and Anatomically Adaptive Approach to Photon and Proton Beam Radiotherapy
Enrollment Status: Completed
Publish Date: July 22, 2022
Intervention Type: Diagnostic test
Study Phase: Not Applicable
Feasibility and PhaseI/II Trial of Preoperative Proton Beam Radiotherapy With Concurrent Chemotherapy for Resectable Stage IIIA or Superior Sulcus NSCLC
Feasibility and PhaseI/II Trial of Preoperative Proton Beam Radiotherapy With Concurrent Chemotherapy for Resectable Stage IIIA or Superior Sulcus NSCLC
Enrollment Status: Completed
Publish Date: May 17, 2021
Intervention Type: Drug, Procedure, Radiation
Study Phase: Phase 1/Phase 2
View 10 Less Clinical Trials

625 Total Publications

Bragg-peak FLASH Biological Optimization Enables Enhanced Normal Tissue Sparing and Dose Escalation for Ocular Stereotactic Body Radiation Therapy.
Bragg-peak FLASH Biological Optimization Enables Enhanced Normal Tissue Sparing and Dose Escalation for Ocular Stereotactic Body Radiation Therapy.
Journal: Physics in medicine and biology
Published: October 02, 2025
Similar Doctors
Distinguished in Thymectomy
Dr. Arvind S. Kumar
Hematology Oncology | Hematology | Oncology
Distinguished in Thymectomy
Dr. Arvind S. Kumar
Hematology Oncology | Hematology | Oncology

Regional Cancer Care Associates LLC

15 Main St, 
Edison, NJ 
 (25.1 miles away)
908-755-1165
Languages Spoken:
English, Hindi, Telugu
See accepted insurances
Accepting New Patients
Offers Telehealth

Arvind Kumar is a Hematologist Oncology specialist and a Hematologist in Edison, New Jersey. Dr. Kumar is rated as a Distinguished provider by MediFind in Thymectomy. His top areas of expertise are Thymic Epithelial Tumor, Mucormycosis, Leukocytosis, Thymectomy, and Endoscopy. Dr. Kumar is currently accepting new patients.

Experienced in Thymectomy
Dr. Wei A. Song
Hematology Oncology
Experienced in Thymectomy
Dr. Wei A. Song
Hematology Oncology

Pottstown Hospital LLC

1600 E High St, 
Pottstown, PA 
 (47.3 miles away)
610-327-7000
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Wei Song is a Hematologist Oncology provider in Pottstown, Pennsylvania. Dr. Song is rated as a Distinguished provider by MediFind in Thymectomy. His top areas of expertise are Lung Cancer, Small Cell Lung Cancer (SCLC), Lung Adenocarcinoma, Adenoidectomy, and Endoscopy.

Experienced in Thymectomy
Dr. Tracey L. Evans
Hematology Oncology | Hematology | Oncology
Experienced in Thymectomy
Dr. Tracey L. Evans
Hematology Oncology | Hematology | Oncology

Einstein Practice Plan Inc

609 W Germantown Pike, 280 Instein Medical Oncolo, 
East Norriton, PA 
 (34.3 miles away)
484-622-7440
Languages Spoken:
English
See accepted insurances
Offers Telehealth

Tracey Evans is a Hematologist Oncology specialist and a Hematologist in East Norriton, Pennsylvania. Dr. Evans is rated as a Distinguished provider by MediFind in Thymectomy. Her top areas of expertise are Lung Cancer, Non-Small Cell Lung Cancer (NSCLC), Small Cell Lung Cancer (SCLC), Tissue Biopsy, and Thymectomy.

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Dr. Simone's expertise for a condition
ConditionClose
    View All 31 Experienced Conditions
    Want to save this doctor for later?
    Sign Up
    Is this your doctor?
    Find A Second Opinion
    Not sure about your diagnosis?
    Check Your Symptoms
     
     
     
     
    Learn about our expert tiers
    Learn More
    Are you the provider on this profile?
    Claim Profile